Caring for Children and Adolescents with Osteosarcoma: A Nursing Perspective

  • Margaret Pearson
Part of the Cancer Treatment and Research book series (CTAR, volume 152)


The nurse plays a vital role in caring for patients with osteosarcoma. From the very outset when the disease is explained to the patient and his/her family, the nurse provides comfort and support, as well as enhances and explains the information provided by the physician. All aspects of medical care are addressed, and he/she is frequently the first line of communication when the patient telephones and requests information or wishes to report a problem to the physician. He/She arranges and coordinates appointments to suit the patient’s medical, and often social needs to provide comprehensive care with attention to detail. This communication will provide a perspective of the role assumed by the nurse in his/her effort to ensure total care of the patient and the family.


Anticipatory Nausea Bowel Management Outpatient Chemotherapy Page Summary Flash Drive 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hinds PS, Gattuso JS, Fletcher A, et al. Quality of life as conveyed by pediatric patients with cancer. Qual Life Res. 2004;13:761-772.CrossRefPubMedGoogle Scholar
  2. 2.
    Eichner J, Johnson B. Family-centered care and the pediatrician’s role. Pediatrics. 2003;112:691-697.CrossRefGoogle Scholar
  3. 3.
    Donnelly JP, Huff SM, Lindsey ML, et al. The needs of children with life-limiting conditions: a healthcare-provider-based model. Am J Hosp Palliat Care. 2005;22:259-267.CrossRefPubMedGoogle Scholar
  4. 4.
    Anderson P, Salazar-Abshire M. Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives. Curr Oncol Rep. 2006;8:415-422.CrossRefPubMedGoogle Scholar
  5. 5.
    Bell DHM, Triche L, Pearson P, Wells P. Flash drive poster: empowerment of families. Third Annual Oncology Nursing Symposium: Excellence Through Innovation. MDACC; 2008Google Scholar
  6. 6.
    Aguilera D, Hayes-Jordan A, Anderson P, et al. Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor. Sarcoma. 2008;2008:261589.CrossRefPubMedGoogle Scholar
  7. 7.
    Anderson P, Aguilera D, Pearson M, Woo S. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Control. 2008;15:38-46.PubMedGoogle Scholar
  8. 8.
    Lashlee M, O’Hanlon Curry J. Pediatric home chemotherapy: infusing “quality of life”. J Pediatr Oncol Nurs. 2007;24:294-298.CrossRefPubMedGoogle Scholar
  9. 9.
    Pearson M, Salazar-Abshire M, Koontzs S. Continuous infusion ifosfamide/mesna: an opportunity for outpatient therapy. 31st Association of Pediatric Hematology/Oncology Nurses; 2007:74Google Scholar
  10. 10.
    Skubitz KM, Hamdan H, Thompson RC Jr. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas. Cancer. 1993;72:2963-2969.CrossRefPubMedGoogle Scholar
  11. 11.
    Hockenberry-Eaton M. Pain Management in Children with Cancer. Texas Cancer Council; 1999:71Google Scholar
  12. 12.
    Tomlinson D, Judd P, Hendershot E, et al. Establishing literature-based items for an oral mucositis assessment tool in children. J Pediatr Oncol Nurs. 2008;25:139-147.CrossRefPubMedGoogle Scholar
  13. 13.
    Tomlinson D, Isitt JJ, Barron RL, et al. Determining the understandability and acceptability of an oral mucositis daily questionnaire. J Pediatr Oncol Nurs. 2008;25:107-111.CrossRefPubMedGoogle Scholar
  14. 14.
    Hunt TL, Gallagher SC, Cullen MT Jr, Shah AK. Evaluation of safety and pharmacokinetics of consecutive multiple-day dosing of palonosetron in healthy subjects. J Clin Pharmacol. 2005;45:589-596.CrossRefPubMedGoogle Scholar
  15. 15.
    Shah AK, Hunt TL, Gallagher SC, Cullen MT Jr. Pharmacokinetics of palonosetron in combination with aprepitant in healthy volunteers. Curr Med Res Opin. 2005;21:595-601.CrossRefPubMedGoogle Scholar
  16. 16.
    Smith AR, Repka TL, Weigel BJ. Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents. Pediatr Blood Cancer. 2005;45:857-860.CrossRefPubMedGoogle Scholar
  17. 17.
    Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005;21:216-222.CrossRefPubMedGoogle Scholar
  18. 18.
    Anderson P. Osteosarcoma relapse: expect the worst, but hope for the best. Pediatr Blood Cancer. 2005;47:231-238.CrossRefGoogle Scholar
  19. 19.
    Pearson M. Historical perspective of the treatment of osteosarcoma: an interview with Dr Norman Jaffe. J Pediatr Oncol Nurs. 1998;15:90-94.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Advanced Nurse Practitioner for the Solid Tumor ServiceChildren’s Cancer Hospital, The University of Texas M. D., Anderson Cancer CenterHoustonUSA

Personalised recommendations